Compile Data Set for Download or QSAR
maximum 50k data
Found 99 with Last Name = 'inoyama' and Initial = 'd'
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615666((5-isopropyl-1H-pyrazol-3-yl)[(1R,5S,6r)-6-(1H-tet...)
Affinity DataIC50:  4nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608104(US11691968, Example 134)
Affinity DataIC50:  4nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615664((5-isopropyl-1H-pyrazol-3-yl)[(1R,5S,6r)-6-(6-meth...)
Affinity DataIC50:  10nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615641((1-isopropyl-1H-imidazol-4-yl)[(1R,5S,6r)-6-(1H-te...)
Affinity DataIC50:  10nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608078(US11691968, Example 62)
Affinity DataIC50:  10nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608079(US11691968, Example 63)
Affinity DataIC50:  10nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615640((1-isopropyl-1H-imidazol-4-yl)[(1R,5S,6r)-6-([1,2,...)
Affinity DataIC50:  10nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608102(US11691968, Example 131)
Affinity DataIC50:  10nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608089((1-cyclopropyl-1H-imidazol-4-yl)[(1R,5S,6r)-6-meth...)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615647((1-isopropyl-1H-imidazol-4-yl){(1R,5S,6r)-6-[(4-me...)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615642((1R,5S,6r)-N-tert-butyl-3-[1-(propan-2-yl)-1H-imid...)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615638((1-isopropyl-1H-imidazol-4-yl)[(1R,5S,6r)-6-(4,5,5...)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615636((1-isopropyl-1H-imidazol-4-yl)[(1R,5S,6r)-6-(5-met...)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608073((1-cyclopropyl-1H-imidazol-4-yl)[(1R,5S,6r)-6-(4-o...)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608065(US11691968, Example 1 | US20230271952, Example 1 |...)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615669((5-cyclopropyl-1H-pyrazol-3-yl)[(1R,5S,6r)-6-methy...)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608089((1-cyclopropyl-1H-imidazol-4-yl)[(1R,5S,6r)-6-meth...)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608085(US11691968, Example 77)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608080(US11691968, Example 65)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608076(US11691968, Example 59)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608074(US11691968, Example 55)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608073((1-cyclopropyl-1H-imidazol-4-yl)[(1R,5S,6r)-6-(4-o...)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608065(US11691968, Example 1 | US20230271952, Example 1 |...)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608107(US11691968, Example 144)
Affinity DataIC50:  20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608094(US11691968, Example 96)
Affinity DataIC50:  30nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608087((1-cyclopropyl-1H-imidazol-4-yl)[(1R,5S,6r)-6-(5,5...)
Affinity DataIC50:  30nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615650((1-isopropyl-1H-imidazol-4-yl)[(1R,5S,6r)-6-methyl...)
Affinity DataIC50:  30nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608071(US11691968, Example 33 | US20230271952, Example 33...)
Affinity DataIC50:  30nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615656((5-isopropyl-1H-pyrazol-3-yl){(1R,5S,6r)-6-[(1S,5S...)
Affinity DataIC50:  30nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608087((1-cyclopropyl-1H-imidazol-4-yl)[(1R,5S,6r)-6-(5,5...)
Affinity DataIC50:  30nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608071(US11691968, Example 33 | US20230271952, Example 33...)
Affinity DataIC50:  30nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615643((1R,5S,6r)-N-tert-butyl-N-methyl-3-[1-(propan-2-yl...)
Affinity DataIC50:  30nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608081(US11691968, Example 66)
Affinity DataIC50:  30nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608088(US11691968, Example 84)
Affinity DataIC50:  30nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615652((1R,5S,6r)-N-tert-butyl-6-methyl-3-[1-(propan-2-yl...)
Affinity DataIC50:  40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615658(US20230271952, Example 104 | {(1R,5S,6r)-6-[5-(dif...)
Affinity DataIC50:  40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615659((5-isopropyl-1H-pyrazol-3-yl){(1R,5S,6r)-6-[5-meth...)
Affinity DataIC50:  40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615662((5-isopropyl-1H-pyrazol-3-yl)[(1R,5S,6r)-6-(4-phen...)
Affinity DataIC50:  40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615663(US20230271952, Example 124 | [(1R,5S,6r)-6-(4-cycl...)
Affinity DataIC50:  40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615665((5-isopropyl-1H-pyrazol-3-yl)[(1R,5S,6r)-6-([1,2,3...)
Affinity DataIC50:  40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608090(US11691968, Example 87)
Affinity DataIC50:  40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608096(US11691968, Example 104)
Affinity DataIC50:  40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608097(US11691968, Example 106)
Affinity DataIC50:  40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608100(US11691968, Example 121)
Affinity DataIC50:  40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608101(US11691968, Example 124)
Affinity DataIC50:  40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608103(US11691968, Example 132)
Affinity DataIC50:  40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608092(US11691968, Example 90)
Affinity DataIC50:  50nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615660(US20230271952, Example 110 | [(1R,5S,6r)-6-(4-ethy...)
Affinity DataIC50:  50nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM615667((1R,5S,6r)-N-(propan-2-yl)-3-[5-(propan-2-yl)-1H-p...)
Affinity DataIC50:  50nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLysine-specific demethylase 5A(Homo sapiens (Human))
Ono Pharmaceutical

US Patent
LigandPNGBDBM608105(US11691968, Example 136)
Affinity DataIC50:  50nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF® technology (Cisbi...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 99 total ) | Next | Last >>
Jump to: